Task: Answer the multiple-choice question.
Question: Which drug has a -11.425% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CNC(=O)CSc1nnc(-c2cnccn2)n1C
b.) COc1ccc2c(c1)c1ncn(Cc3ccc(F)cc3)c(=O)c1n2C
c.) CSc1nc(/C=C2\C=Nc3ccccc32)c(O)n1C
Answer: c. CSc1nc(/C=C2\C=Nc3ccccc32)c(O)n1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSc1nc(/C=C2\C=Nc3ccccc32)c(O)n1C
CSc1nc(/C=C2\C=Nc3ccccc32)c(O)n1C
5-[(Z)-indol-3-ylidenemethyl]-3-methyl-2-methylsulfanylimidazol-4-ol